Iterative Health has partnered with Gastroenterology Associates of New Jersey (GANJ) to expand community-based clinical research across the state. As GANJ’s exclusive research partner, Iterative Health will launch two new research sites in Toms River and Clifton, with plans to add more across GANJ’s 28-location network. The collaboration aims to make clinical trials more accessible by embedding research into routine gastroenterology care, giving patients access to investigational therapies closer to home.
The partnership combines GANJ’s network of 60+ healthcare professionals with Iterative Health’s clinical trial infrastructure, sponsor relationships, and AI-powered research platform. A major focus will be inflammatory bowel disease (IBD), building on GANJ’s recently established Comprehensive IBD Care Center and Iterative Health’s expertise in GI clinical development. The collaboration is expected to accelerate patient enrollment in clinical trials while generating more diverse, real-world evidence from New Jersey’s large and ethnically diverse population.